RxDoctor Payments Data

Kerry Paulson, NP

Adult Health · Hopkins, MNNPI 1518363407

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations.

$304in general payments, 2019–2025

Across 14 payments — averaging $21.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • 180 Medical, Inc.$54
  • Johnson & Johnson$49
  • AVEO Pharmaceuticals, Inc.$40
  • Dendreon Pharmaceuticals LLC$34
  • Sumitomo Pharma America, Inc.$25
  • Novartis$22
  • plus $80 from 5 others

What the payments were for

  • Food & beverage$304100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$304 in reported general payments places this provider in the 70th percentile of 233 adult health providers in Minnesota.

See all adult health providers in Minnesota

Medicare billing

Part B allowed, 2024
$48,828
Medicare patients
306
Services billed
543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron52$57,848
GemtesaVibegron31$23,397
Tamsulosin Hcl257$4,281
Estradiol24$2,252
Tadalafil20$1,828
Finasteride106$1,477
Dutasteride19$1,142
Alfuzosin Hcl ErAlfuzosin Hcl38$923
Oxybutynin Chloride ErOxybutynin Chloride23$647
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim31$133
Ciprofloxacin Hcl13$10

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$25$23,39731 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 233 adult health providers in Minnesota.

Other adult health in Hopkins

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →